Financhill
Back

Akero Therapeutics Stock Predictions

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 69.7% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $52.00. The Score for AKRO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 69.7% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Sell
46
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • The current trend is moderately bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
58.40
52-Week Low:
21.34

Prediction Charts

Market Cap:
4.1B
Price in USD:
52.00
Volume:
778.8K
Beta:
-0.03

Technical Analysis

SMA50:
49.03
SMA100:
46.04
SMA200:
39.09
52-Wk Change:
116.67%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 52.00 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-20 54.59 54.20 55.00 53.90
Jun-23 53.64 54.03 54.33 52.76
Jun-24 54.10 53.92 54.96 53.37
Jun-25 54.39 55.04 55.52 53.05
Jun-26 55.80 56.28 56.94 54.00
Jun-27 56.03 56.19 57.35 55.03
Jun-30 56.51 53.36 56.51 53.06
Jul-1 52.81 51.41 53.83 51.12
Jul-2 51.16 51.88 52.60 51.08
Jul-3 51.55 51.77 52.30 51.11
Jul-7 51.85 51.52 52.73 50.57
Jul-8 51.55 50.37 52.07 50.13
Jul-9 51.00 51.13 53.60 50.97
Jul-10 50.82 52.00 52.07 50.04

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.